The multiplication of the CYP2C8*3 allele is not expected to increase paclitaxel-metabolizing activity of the tumour cells; therefore, the multiplication of the functional wild-type allele is reasonable to consider in a tumour. The gene discussed is CYP2C8; the disease is neoplasm.